Cargando…

The Brain Activity in Brodmann Area 17: A Potential Bio-Marker to Predict Patient Responses to Antiepileptic Drugs

In this study, we aimed to predict newly diagnosed patient responses to antiepileptic drugs (AEDs) using resting-state functional magnetic resonance imaging tools to explore changes in spontaneous brain activity. We recruited 21 newly diagnosed epileptic patients, 8 drug-resistant (DR) patients, 11...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yida, Mi, Xiujuan, Xu, Xin, Fang, Weidong, Zeng, Kebin, Yang, Mingming, Li, Chenyu, Wang, Shasha, Li, Minghui, Wang, Xuefeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595505/
https://www.ncbi.nlm.nih.gov/pubmed/26439500
http://dx.doi.org/10.1371/journal.pone.0139819
_version_ 1782393619078971392
author Hu, Yida
Mi, Xiujuan
Xu, Xin
Fang, Weidong
Zeng, Kebin
Yang, Mingming
Li, Chenyu
Wang, Shasha
Li, Minghui
Wang, Xuefeng
author_facet Hu, Yida
Mi, Xiujuan
Xu, Xin
Fang, Weidong
Zeng, Kebin
Yang, Mingming
Li, Chenyu
Wang, Shasha
Li, Minghui
Wang, Xuefeng
author_sort Hu, Yida
collection PubMed
description In this study, we aimed to predict newly diagnosed patient responses to antiepileptic drugs (AEDs) using resting-state functional magnetic resonance imaging tools to explore changes in spontaneous brain activity. We recruited 21 newly diagnosed epileptic patients, 8 drug-resistant (DR) patients, 11 well-healed (WH) patients, and 13 healthy controls. After a 12-month follow-up, 11 newly diagnosed epileptic patients who showed a poor response to AEDs were placed into the seizures uncontrolled (SUC) group, while 10 patients were enrolled in the seizure-controlled (SC) group. By calculating the amplitude of fractional low-frequency fluctuations (fALFF) of blood oxygen level-dependent signals to measure brain activity during rest, we found that the SUC patients showed increased activity in the bilateral occipital lobe, particularly in the cuneus and lingual gyrus compared with the SC group and healthy controls. Interestingly, DR patients also showed increased activity in the identical cuneus and lingual gyrus regions, which comprise Brodmann’s area 17 (BA17), compared with the SUC patients; however, these abnormalities were not observed in SC and WH patients. The receiver operating characteristic (ROC) curves indicated that the fALFF value of BA17 could differentiate SUC patients from SC patients and healthy controls with sufficient sensitivity and specificity prior to the administration of medication. Functional connectivity analysis was subsequently performed to evaluate the difference in connectivity between BA17 and other brain regions in the SUC, SC and control groups. Regions nearby the cuneus and lingual gyrus were found positive connectivity increased changes or positive connectivity changes with BA17 in the SUC patients, while remarkably negative connectivity increased changes or positive connectivity decreased changes were found in the SC patients. Additionally, default mode network (DMN) regions showed negative connectivity increased changes or negative changes with BA17 in the SUC patients. The abnormal increased in BA17 activity may be a key point that plays a substantial role in facilitating seizure onset.
format Online
Article
Text
id pubmed-4595505
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-45955052015-10-09 The Brain Activity in Brodmann Area 17: A Potential Bio-Marker to Predict Patient Responses to Antiepileptic Drugs Hu, Yida Mi, Xiujuan Xu, Xin Fang, Weidong Zeng, Kebin Yang, Mingming Li, Chenyu Wang, Shasha Li, Minghui Wang, Xuefeng PLoS One Research Article In this study, we aimed to predict newly diagnosed patient responses to antiepileptic drugs (AEDs) using resting-state functional magnetic resonance imaging tools to explore changes in spontaneous brain activity. We recruited 21 newly diagnosed epileptic patients, 8 drug-resistant (DR) patients, 11 well-healed (WH) patients, and 13 healthy controls. After a 12-month follow-up, 11 newly diagnosed epileptic patients who showed a poor response to AEDs were placed into the seizures uncontrolled (SUC) group, while 10 patients were enrolled in the seizure-controlled (SC) group. By calculating the amplitude of fractional low-frequency fluctuations (fALFF) of blood oxygen level-dependent signals to measure brain activity during rest, we found that the SUC patients showed increased activity in the bilateral occipital lobe, particularly in the cuneus and lingual gyrus compared with the SC group and healthy controls. Interestingly, DR patients also showed increased activity in the identical cuneus and lingual gyrus regions, which comprise Brodmann’s area 17 (BA17), compared with the SUC patients; however, these abnormalities were not observed in SC and WH patients. The receiver operating characteristic (ROC) curves indicated that the fALFF value of BA17 could differentiate SUC patients from SC patients and healthy controls with sufficient sensitivity and specificity prior to the administration of medication. Functional connectivity analysis was subsequently performed to evaluate the difference in connectivity between BA17 and other brain regions in the SUC, SC and control groups. Regions nearby the cuneus and lingual gyrus were found positive connectivity increased changes or positive connectivity changes with BA17 in the SUC patients, while remarkably negative connectivity increased changes or positive connectivity decreased changes were found in the SC patients. Additionally, default mode network (DMN) regions showed negative connectivity increased changes or negative changes with BA17 in the SUC patients. The abnormal increased in BA17 activity may be a key point that plays a substantial role in facilitating seizure onset. Public Library of Science 2015-10-06 /pmc/articles/PMC4595505/ /pubmed/26439500 http://dx.doi.org/10.1371/journal.pone.0139819 Text en © 2015 Hu et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Hu, Yida
Mi, Xiujuan
Xu, Xin
Fang, Weidong
Zeng, Kebin
Yang, Mingming
Li, Chenyu
Wang, Shasha
Li, Minghui
Wang, Xuefeng
The Brain Activity in Brodmann Area 17: A Potential Bio-Marker to Predict Patient Responses to Antiepileptic Drugs
title The Brain Activity in Brodmann Area 17: A Potential Bio-Marker to Predict Patient Responses to Antiepileptic Drugs
title_full The Brain Activity in Brodmann Area 17: A Potential Bio-Marker to Predict Patient Responses to Antiepileptic Drugs
title_fullStr The Brain Activity in Brodmann Area 17: A Potential Bio-Marker to Predict Patient Responses to Antiepileptic Drugs
title_full_unstemmed The Brain Activity in Brodmann Area 17: A Potential Bio-Marker to Predict Patient Responses to Antiepileptic Drugs
title_short The Brain Activity in Brodmann Area 17: A Potential Bio-Marker to Predict Patient Responses to Antiepileptic Drugs
title_sort brain activity in brodmann area 17: a potential bio-marker to predict patient responses to antiepileptic drugs
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595505/
https://www.ncbi.nlm.nih.gov/pubmed/26439500
http://dx.doi.org/10.1371/journal.pone.0139819
work_keys_str_mv AT huyida thebrainactivityinbrodmannarea17apotentialbiomarkertopredictpatientresponsestoantiepilepticdrugs
AT mixiujuan thebrainactivityinbrodmannarea17apotentialbiomarkertopredictpatientresponsestoantiepilepticdrugs
AT xuxin thebrainactivityinbrodmannarea17apotentialbiomarkertopredictpatientresponsestoantiepilepticdrugs
AT fangweidong thebrainactivityinbrodmannarea17apotentialbiomarkertopredictpatientresponsestoantiepilepticdrugs
AT zengkebin thebrainactivityinbrodmannarea17apotentialbiomarkertopredictpatientresponsestoantiepilepticdrugs
AT yangmingming thebrainactivityinbrodmannarea17apotentialbiomarkertopredictpatientresponsestoantiepilepticdrugs
AT lichenyu thebrainactivityinbrodmannarea17apotentialbiomarkertopredictpatientresponsestoantiepilepticdrugs
AT wangshasha thebrainactivityinbrodmannarea17apotentialbiomarkertopredictpatientresponsestoantiepilepticdrugs
AT liminghui thebrainactivityinbrodmannarea17apotentialbiomarkertopredictpatientresponsestoantiepilepticdrugs
AT wangxuefeng thebrainactivityinbrodmannarea17apotentialbiomarkertopredictpatientresponsestoantiepilepticdrugs
AT huyida brainactivityinbrodmannarea17apotentialbiomarkertopredictpatientresponsestoantiepilepticdrugs
AT mixiujuan brainactivityinbrodmannarea17apotentialbiomarkertopredictpatientresponsestoantiepilepticdrugs
AT xuxin brainactivityinbrodmannarea17apotentialbiomarkertopredictpatientresponsestoantiepilepticdrugs
AT fangweidong brainactivityinbrodmannarea17apotentialbiomarkertopredictpatientresponsestoantiepilepticdrugs
AT zengkebin brainactivityinbrodmannarea17apotentialbiomarkertopredictpatientresponsestoantiepilepticdrugs
AT yangmingming brainactivityinbrodmannarea17apotentialbiomarkertopredictpatientresponsestoantiepilepticdrugs
AT lichenyu brainactivityinbrodmannarea17apotentialbiomarkertopredictpatientresponsestoantiepilepticdrugs
AT wangshasha brainactivityinbrodmannarea17apotentialbiomarkertopredictpatientresponsestoantiepilepticdrugs
AT liminghui brainactivityinbrodmannarea17apotentialbiomarkertopredictpatientresponsestoantiepilepticdrugs
AT wangxuefeng brainactivityinbrodmannarea17apotentialbiomarkertopredictpatientresponsestoantiepilepticdrugs